Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.
Cambodia begins to offer the Oxford-AstraZeneca COVID-19 vaccine as a third "booster" dose to those who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (Coronavac) in order to bolstering immunity against the SARS-CoV-2 Delta variant.
Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.